Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Storkus

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Melanoma Research|February 1, 1996
New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccinesM J Maeurer, W J Storkus, J M Kirkwood, et al.
Natural Immunity|April 1, 1995
Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEAM Maeurer, L Zitvogel, E Elder, et al.
Gene Therapy|September 7, 1999
Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigenT Tüting, A Gambotto, P D Robbins, et al.
Annals of the New York Academy of Sciences|October 31, 1996
Murine models of cancer cytokine gene therapy using interleukin-12H Tahara, L Zitvogel, W J Storkus, et al.
Blood|August 29, 2000
Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responsesW Herr, E Ranieri, W Olson, et al.
Cancer Research|September 15, 2000
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cellsH M Zarour, W J Storkus, V Brusic, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genesW J Storkus, J Alexander, J A Payne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killingW J Storkus, J Alexander, J A Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysisM J Maeurer, D Martin, E Elder, et al.
The Cancer Journal From Scientific American|July 1, 1995
Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usageM J Maeurer, S Hurd, D M Martin, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Melanoma Research|February 1, 1996
New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccinesM J Maeurer, W J Storkus, J M Kirkwood, et al.
Natural Immunity|April 1, 1995
Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEAM Maeurer, L Zitvogel, E Elder, et al.
Gene Therapy|September 7, 1999
Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigenT Tüting, A Gambotto, P D Robbins, et al.
Annals of the New York Academy of Sciences|October 31, 1996
Murine models of cancer cytokine gene therapy using interleukin-12H Tahara, L Zitvogel, W J Storkus, et al.
Blood|August 29, 2000
Mature dendritic cells pulsed with freeze-thaw cell lysates define an effective in vitro vaccine designed to elicit EBV-specific CD4(+) and CD8(+) T lymphocyte responsesW Herr, E Ranieri, W Olson, et al.
Cancer Research|September 15, 2000
NY-ESO-1 encodes DRB1*0401-restricted epitopes recognized by melanoma-reactive CD4+ T cellsH M Zarour, W J Storkus, V Brusic, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989
Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genesW J Storkus, J Alexander, J A Payne, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killingW J Storkus, J Alexander, J A Payne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysisM J Maeurer, D Martin, E Elder, et al.
The Cancer Journal From Scientific American|July 1, 1995
Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usageM J Maeurer, S Hurd, D M Martin, et al.
Pageof 8